Abstract
Selective inhibition of inducible nitric oxide synthases (iNOS) has been a challenging problem for researchers pursuing work in finding methods to treat inflammatory disorders, shock, etc. Though many inhibitors have been studied to date, all are associated with selectivity or potency problems. Additionally, most of the reported compounds have several similarities and fewer number of novel structures are being tried. There is an increasing need to design novel molecules for this target. In this work, de novo design using LUDI, combined with docking analysis using FlexX has been employed in an attempt to identify novel scaffolds. Benzene-1,2-diamines were identified which could mimic the interactions of the substrate analogs and other inhibitors. Comparative docking scores in each of the isoforms of nitric oxide synthase were employed to recognize hits for iNOS selectivity.
Similar content being viewed by others
References
Kerwin Jr JF, Lancaster JR, Feldman PL (1995) J Med Chem 38:4343–4362
Hansen DW, Peterson KB, Trivedi M, Kramer SW, Webber RK, Tjoeng FS, Moore WM, Jerome GM, Kornmeier CM, Manning PT, Connor JR, Misko TP, Currie MG, Pitzele BS (1998) J Med Chem 41:1361–1366
Marletta MA (1994) J Med Chem 37:1899–1907
Knowles RG, Moncada S (1994) Biochem J 298:249–258
Crane BR, Arvai AS, Ghosh DK, Wu C, Getzoff ED, Stuehr DJ, Tainer JA (1998) Science 279:2121–2126
Crane BR, Arvai AS, Gachhui R, Wu C, Ghosh DK, Getzoff ED, Stuehr DJ, Tainer JA (1997) Science 278:425–431
Ji H, Li H, Flinspach M, Poulos TL, Silverman RB (2003) J Med Chem 46:5700–5711
Li H, Poulos TL (2005) J Inorg Biochem 99:293–305
Fischmann TO, Hruza A, Niu XD, Fossetta JD, Lunn CA, Dolphin E, Prongay AJ, Reichert P, Lundell DJ, Narula SK, Weber PC (1999) Nat Struct Biol 6:233–242
Li H, Raman CS, Glaser CB, Blasko E, Young TA, Parkinson JF, Whitlow M, Poulos TL (1999) J Biol Chem 274:21276–21284
Fedorov R, Vasan R, Ghosh DK, Schlichting I (2004) Proc Natl Acad Sci USA 101:5892–5897
Alderton WK, Cooper CE, Knowles RG (2001) Biochem J 357:593–615
Olken NM, Marletta MA (1993) Biochemistry 32:9677–9685
Furfine ES, Harmon MF, Paith JE, Garvey EP (1993) Biochemistry 32:8512–8517
McCall TB, Feelisch M, Palmer RM, Moncada S (1991) Br J Pharmacol 102:234–238
Babu BR, Griffith OW (1998) J Biol Chem 273:8882–8889
Narayanan K, Griffith OW (1994) J Med Chem 37:885–887
Moore WM, Webber RK, Jerome GM, Tjoeng FS, Misko TP, Currie MG (1994) J Med Chem 37:3886–3888
Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, McDaniel ML, Williamson JR, Currie MG (1993) Eur J Pharmacol 233:119–125
Garvey EP, Oplinger JA, Tanoury GJ, Sherman PA, Fowler M, Marshall S, Harmon MF, Paith JE, Furfine ES (1994) J Biol Chem 269:26669–26676
Southan GJ, Szabo C, Thiemermann C (1995) Br J Pharmacol 114:510–516
Moore WM, Webber RK, Fok KF, Jerome GM, Connor JR, Manning PT, Wyatt PS, Misko TP, Tjoeng FS, Currie MG (1996) J Med Chem 39:669–672
Hagen TJ, Bergmanis AA, Kramer SW, Fok KF, Schmelzer AE, Pitzele BS, Swenton L, Jerome GM, Kornmeier CM, Moore WM, Branson LF, Connor JR, Manning PT, Currie MG, Hallinan EA (1998) J Med Chem 41:3675–3683
Beaton H, Boughton-Smith N, Hamley P, Ghelani A, Nicholls DJ, Tinker AC, Wallace AV (2001) Bioorg Med Chem Lett 11:1027–1030
Beaton H, Hamley P, Nicholls DJ, Tinker AC, Wallace AV (2001) Bioorg Med Chem Lett 11:1023–1026
Tinker AC, Beaton HG, Boughton-Smith N, Cook TR, Cooper SL, Fraser-Rae L, Hallam K, Hamley P, McInally T, Nicholls DJ, Pimm AD, Wallace AV (2003) J Med Chem 46:913–916
Connolly S, Aberg A, Arvai A, Beaton HG, Cheshire DR, Cook AR, Cooper S, Cox D, Hamley P, Mallinder P, Millichip I, Nicholls DJ, Rosenfeld RJ, St-Gallay SA, Tainer J, Tinker AC, Wallace AV (2004) J Med Chem 47:3320–3323
Kawanaka Y, Kobayashi K, Kusuda S, Tatsumi T, Murota M, Nishiyama T, Hisaichi K, Fujii A, Hirai K, Naka M (2003) Bioorg Med Chem 11:1723–1743
Kawanaka Y, Kobayashi K, Kusuda S, Tatsumi T, Murota M, Nishiyama T, Hisaichi K, Fujii A, Hirai K, Nishizaki M, Naka M, Komeno M, Nakai H, Toda M (2003) Bioorg Med Chem 11:689–702
Ueda S, Terauchi H, Kawasaki M, Yano A, Ido M (2004) Chem Pharm Bull 52:634–637
Ueda S, Terauchi H, Yano A, Ido M, Matsumoto M, Kawasaki M (2004) Bioorg Med Chem Lett 14:313–316
Ueda S, Terauchi H, Yano A, Matsumoto M, Kubo T, Kyoya Y, Suzuki K, Ido M, Kawasaki M (2004) Bioorg Med Chem 12:4101–4116
Ueda S, Terauchi H, Suzuki K, Yano A, Matsumoto M, Kubo T, Minato H, Arai YT, Suji J, Watanabe N (2005) Bioorg Med Chem Lett 15:1361–1366
Strub A, Ulrich WR, Hesslinger C, Eltze M, Fuchss T, Strassner J, Strand S, Lehner MD, Boer R (2006) Mol Pharmacol 69:328–337
Naka M, Nanbu T, Kobayashi K, Kamanaka Y, Komeno M, Yanase R, Fukutomi T, Fujimura S, Seo HG, Fujiwara N, Ohuchida S, Suzuki K, Kondo K, Taniguchi N (2000) Biochem Biophys Res Commun 270:663–667
Young RJ, Beams RM, Carter K, Clark HA, Coe DM, Chambers CL, Davies PI, Dawson J, Drysdale MJ, Franzman KW, French C, Hodgson ST, Hodson HF, Kleanthous S, Rider P, Sanders D, Sawyer DA, Scott KJ, Shearer BG, Stocker R, Smith S, Tackley MC, Knowles RG (2000) Bioorg Med Chem Lett 10:597–600
Salerno L, Sorrenti V, Di Giacomo C, Romeo G, Siracusa MA (2002) Curr Pharm Des 8:177–200
Babu BR, Frey C, Griffith OW (1999) J Biol Chem 274:25218–25226
Aparna V, Desiraju G.R, Gopalakrishnan B (2007) J Mol Graph Model 26:457–470
Haitao Ji, Gomez-Vidal, Jose A, Martasek P, Roman LJ, Silverman, RB (2006) J Med Chem 49:6254–6263
Seo J, Igarashi J, Li H, Martasek P, Roman LJ, Poulos TL, Silverman RB (2007) J Med Chem 50:2089–2099
David DD, Adler M, Arnaiz D, Eagen K, Erickson S, Guilford W, Kenrick, M, Morrissey MM, Ohlmeyer M, Pan G, Paradkar VM, Parkinson J, Polokoff M, Saionz K, Santos C, Subramanyam B, Vergona R, Wei RG, Whitlow M, Ye B, Zhao Z, Devlin JJ, Phillips G (2007) J Med Chem 50:1146–1157
Bohm HJ (1994) J Comput Aided Mol Des 8:243–256
Rarey M, Kramer B, Lengauer T, Klebe G (1996) J Mol Biol 261:470–489
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Francis, S.M., Mittal, A., Sharma, M. et al. Design of Benzene-1,2-diamines as selective inducible nitric oxide synthase inhibitors: a combined de novo design and docking analysis. J Mol Model 14, 215–224 (2008). https://doi.org/10.1007/s00894-007-0263-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00894-007-0263-y